State Ledger
Company profile

Citius Pharmaceuticals, Inc. CIK 1506251

Ticker
CTXR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cranford, NJ 07016
Fiscal year end
2025 (FY)
Market Data
Close
$0.48
Change
-$0.02
Change %
-3.45%
Volume
2,339

CTXR · trading date Oct 12, 2026 · previous close $0.50 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$37.43M
Total assets
$130.94M
Total liabilities
$53.41M
Stockholders' equity
$67.55M
Cash & equivalents
$4.25M
Operating income
-$38.53M
Operating cash flow
-$26.55M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2025-12-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
40.8%
Equity / assets
51.6%
CapEx / revenue
—
Operating cash flow / net income
0.71×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$37.43M $130.94M $53.41M $67.55M
2024 — -$39.14M $116.65M $42.55M $70.08M
2023 — -$32.54M $103.61M $12.18M $90.83M
2022 — -$33.64M $114.00M $10.57M $102.83M
2021 — -$23.05M $142.43M $9.65M $132.18M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-21
Financials filed via
Form 10-K
filed 2025-12-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cranford, NJ 07016
11 COMMERCE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies